Averting toxic side effects from CAR-T cancer treatments – FierceBiotech
FierceBiotech |
Averting toxic side effects from CAR–T cancer treatments
FierceBiotech To identify the biomarkers, the research team closely tracked 133 patients participating in a trial of a CAR–T that was developed at Fred Hutch to treat chronic lymphocytic leukemia, non-Hodgkin lymphoma or acute lymphoblastic leukemia. They timed the … Our best chance to end cancer |
